covaxin: Good news! Covacin able to eliminate the delta variant of the corona, front of the study

New Delhi: There is good news about Covacin vaccine on Bharat Biotech’s corona. Covaxin is also effective against delta variants on the Alpha (B.1.1.7) and Delta (B.1.617) variants of Corona. This is according to a study by the National Institutes of Health (NIH), a leading US health research organization.

The NIH had studied the blood serum of citizens who had been vaccinated with the covacin vaccine. The covacin vaccine is effective on the Alpha and Delta variants of Corona. It is also capable of producing antibodies, the study found. The delta variant of the Corona had created a critical situation in India in the second wave.

Our adjuvants have helped make covacin more effective. Edjuvend is a chemical. Which enhances immunity. These are commonly used to enhance the effect of the vaccine. This chemical helps the body to increase immunity. Which fights against antigens. India imports these chemicals from the US and Europe.

Covacin is also 100% effective in preventing serious infections

The vaccine is safe based on the results of the second phase of the vaccine, the NIH said. Data for the third phase of the vaccine will also be available soon. Coronary coronary infections are 78 per cent effective against severe infections, 100 per cent effective against severe infections and 70 per cent effective against asymptomatic infections.

Supreme Court: Compensate the families of patients who die in Corona, Supreme Court directs

Kovacin may receive WHO approval this month. The WHO has applied for WHO approval on June 23. The vaccine is expected to be approved after the third phase of covacin test data is submitted to the WHO.

coronavirus india: threat of third wave of coronavirus; The Center gave instructions to the states